Dr Reddy's Laboratories. Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 24,03,285 shares,. Its Average Traded Price (ATP) is ₹1167.08, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1165.50.
Dr Reddy's Laboratories. has an upper circuit limit of ₹1257.30 and a lower circuit limit of ₹1028.70. The total value traded stands at ₹280.48 CR, and the delivery percentage for the day is 74.47%.
The stock is currently traded with a market lot size of 1. Dr Reddy's Laboratories. also offers a dividend yield of 0.7%.
Dr Reddy's Laboratories Share Price Chart
Dr Reddy's Laboratories. Share Key Metrics
Volume
24.03 L
Market Cap
97280.68 CR
LTQ@LTP
1@1165.50
ATP
1167.08
Var Margin
12.5 %
Circuit Range
1028.7-1257.3
Delivery %
74.47 %
Value
280.48 CR
ASM/GSM
No
Market Lot
1
Dr Reddy's Laboratories. Resistance and Support
Pivot 1141.7
Resistance
First Resistance
1148.5
Second Resistance
1154
Third Resistance
1160.8
Support
First Support
1136.2
Second Support
1129.4
Third Support
1123.9
Dr Reddy's Laboratories. Futures & Options
1165.5
22.5 (1.97%)
Dr Reddy's Laboratories. Option Chain
View Price, OI, Greeks & More...
29SEP26
1169.00
32.60 (2.87%)
27OCT26
1166.00
30.60 (2.70%)
23NOV26
1171.20
34.20 (3.01%)
DRREDDY|29SEP26 CE 1160.00
23.35
12.05 (106.64%)
DRREDDY|29SEP26 PE 1170.00
20.85
-20.35 (-49.39%)
Dr Reddy's Laboratories. Shareholding Pattern
View More- 2016-17
- 2017-18
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Dr Reddy's Laboratories. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-22 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-01-21 | Quarterly Results |
| 2025-10-24 | Quarterly Results |
| 2025-07-23 | Quarterly Results |
| 2025-05-09 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
| 2024-07-27 | Quarterly Results & Stock Split |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-10 | 2026-07-10 | View More |
| Split Ratio | Split Date | |
|---|---|---|
| 5:1 | 2024-10-28 | View More |
Dr Reddy's Laboratories. News
Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Dr Reddys Laboratories received two observations on Form FDA 2953 from the USFDA following a records assessment at its API manufacturing facility in Jiutepec, Morelos, Mexico. The company will respond to these observations within the stipulated timeline.
Sep 11 2026 22:07:43
Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Reddy's Laboratories management is scheduled to participate in two investor group meetings. The first is with ICICI Securities in Hyderabad on September 17, 2026, and the second is a virtual meeting with Bank of America on September 24, 2026.
Sep 10 2026 17:36:19
Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Dr. Reddy's Laboratories received a USFDA Form 483 with four observations after an inspection at its Bachupally, Hyderabad formulations manufacturing facility. The company will address these observations within the stipulated timeline.
Aug 14 2026 23:29:33
Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Dr. Reddys Laboratories announced that the USFDA inspection of its Mirfield API manufacturing facility in the UK has been officially closed. The inspection outcome was classified as 'Voluntary Action Indicated' (VAI), resolving the previous GMP inspection.
Aug 14 2026 23:04:32
Dr Reddys Laboratories Ltd - 500124 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund increased its stake in Dr Reddys Laboratories Ltd. to 5.037% after acquiring 712,884 shares via open market on August 12, 2026. This acquisition led to crossing the 5% ownership threshold.
Aug 14 2026 12:12:22
Dr Reddy's Laboratories. Management
| Name | Position |
|---|---|
| K Randhir Singh | Company Secretary, Compliance Officer and Head-CSR |
| K Satish Reddy | Chairman |
Dr Reddy's Laboratories. Similar Stocks
Laurus Labs Ltd.
1969.00
24.00 (1.23%)
Max Healthcare Institute Ltd.
1037.70
-0.90 (0.09%)
Aurobindo Pharma Ltd.
1679.80
11.40 (0.68%)
Manipal Health Enterprises Ltd.
717.35
-15.90 (2.17%)
Lupin Ltd.
2095.00
17.20 (0.83%)
Mankind Pharma Ltd.
2280.00
41.60 (1.86%)
Glenmark Pharmaceuticals Ltd.
2419.20
4.20 (0.17%)
Fortis Healthcare Ltd.
887.80
-14.65 (1.62%)
Aster DM Quality Care Ltd.
763.05
-3.45 (0.45%)
Biocon Ltd.
390.65
-1.00 (0.26%)
Dr Reddy's Laboratories. FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in DRREDDY
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC